References
- Tziotzios C, Lee JYW, Brier T, et al. Lichen planus and lichenoid dermatoses: clinical overview and molecular basis. J Am Acad Dermatol. 2018;79(5):1–3. doi:10.1016/j.jaad.2018.02.010.
- Goettmann S, Zaraa I, Moulonguet I. Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases: nail lichen planus. J Eur Acad Dermatol Venereol. 2012;26(10):1304–1309. doi:10.1111/j.1468-3083.2011.04288.x.
- Gupta MK, Lipner SR. Review of nail lichen planus: epidemiology, pathogenesis, diagnosis, and treatment. Dermatol Clin. 2021;39(2):221–230. doi:10.1016/j.det.2020.12.002.
- Boch K, Langan EA, Kridin K, et al. Lichen planus. Front Med. 2021;8:737813. doi:10.3389/fmed.2021.737813.
- Solimani F, Meier K, Ghoreschi K. Emerging topical and systemic JAK inhibitors in dermatology. Front Immunol. 2019;10:2847. doi:10.3389/fimmu.2019.02847.
- Yang CC, Khanna T, Sallee B, et al. Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatol Ther. 2018;31(6):e12656. doi:10.1111/dth.12656.
- Seiringer P, Lauffer F, Pilz A, et al. Tofacitinib in hypertrophic lichen planus. Acta Derm Venereol. 2020;100(14):adv00220. doi:10.2340/00015555-3585.
- Plante J, Eason C, Snyder A, et al. Tofacitinib in the treatment of lichen planopilaris: a retrospective review. J Am Acad Dermatol. 2020;83(5):1487–1489. doi:10.1016/j.jaad.2020.05.104.
- Damsky W, Wang A, Olamiju B, et al. Treatment of severe lichen planus with the JAK inhibitor tofacitinib. J Allergy Clin Immunol. 2020;145(6):1708–1710.e2. doi:10.1016/j.jaci.2020.01.031.
- Iorizzo M, Haneke E. Tofacitinib as treatment for nail lichen planus associated with alopecia universalis. JAMA Dermatol. 2021;157(3):352–353. doi:10.1001/jamadermatol.2020.4555.
- Pünchera J, Laffitte E. Treatment of severe nail lichen planus with baricitinib. JAMA Dermatol. 2022;158(1):107–108. doi:10.1001/jamadermatol.2021.5082.
- Shao S, Tsoi LC, Sarkar MK, et al. IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Sci Transl Med. 2019;11(511):eaav7561. doi:10.1126/scitranslmed.aav7561.
- Di Lernia V. Targeting the IFN-γ/CXCL10 pathway in lichen planus. Med Hypotheses. 2016;92:60–61. doi:10.1016/j.mehy.2016.04.042.